Diploma (LON:DPLM) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says

Diploma (LON:DPLM) had its price target raised by equities research analysts at Deutsche Bank Aktiengesellschaft from GBX 6,200 to GBX 6,400 in a report issued on Thursday,London Stock Exchange reports. The firm presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price points to a potential upside of 10.44% from the stock’s previous close.

A number of other equities research analysts also recently weighed in on DPLM. Berenberg Bank reissued a “buy” rating and set a GBX 6,350 target price on shares of Diploma in a report on Wednesday, November 19th. Shore Capital Group restated a “hold” rating on shares of Diploma in a research note on Wednesday. Stifel Nicolaus raised their price target on shares of Diploma from GBX 6,200 to GBX 6,800 and gave the stock a “buy” rating in a research report on Thursday. Peel Hunt reissued a “buy” rating and issued a GBX 6,150 price objective on shares of Diploma in a report on Friday, December 19th. Finally, Royal Bank Of Canada increased their target price on shares of Diploma from GBX 6,200 to GBX 6,600 and gave the stock an “outperform” rating in a research report on Thursday. Five investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of GBX 6,023.75.

Diploma Stock Performance

LON:DPLM traded down GBX 130 during mid-day trading on Thursday, hitting GBX 5,795. 38,388,117 shares of the stock were exchanged, compared to its average volume of 2,353,902. The firm’s 50-day simple moving average is GBX 5,451.05 and its 200 day simple moving average is GBX 5,421.27. The stock has a market capitalization of £7.77 billion, a price-to-earnings ratio of 42.21, a price-to-earnings-growth ratio of 2.82 and a beta of 1.03. Diploma has a fifty-two week low of GBX 3,532 and a fifty-two week high of GBX 6,019.52. The company has a debt-to-equity ratio of 46.97, a quick ratio of 0.80 and a current ratio of 2.04.

Insider Activity

In other news, insider Katie Bickerstaffe acquired 352 shares of the stock in a transaction on Wednesday, January 14th. The stock was acquired at an average cost of GBX 5,645 per share, for a total transaction of £19,870.40. Also, insider Wilson Ng bought 410 shares of the business’s stock in a transaction on Friday, December 19th. The shares were acquired at an average price of GBX 5,369 per share, with a total value of £22,012.90. Over the last ninety days, insiders acquired 1,262 shares of company stock valued at $6,995,830. 1.14% of the stock is owned by insiders.

Diploma News Roundup

Here are the key news stories impacting Diploma this week:

• Positive Sentiment: Management upgraded FY2026 guidance after a strong first half — the outlook upgrade was described as “significant” and cited resilient aerospace demand as a driver. Read More.
• Positive Sentiment: Market reaction: several outlets report shares surged (up as much as ~17%) after the profit/guidance upgrade, showing the news materially raised investor expectations. Read More.
• Positive Sentiment: Analyst actions: Royal Bank of Canada raised its price target from 6,200p to 6,600p and moved to an “Outperform” rating. Read More., Read More.
• Positive Sentiment: Analyst actions: Stifel Nicolaus lifted its target from 6,200p to 6,800p and put a “Buy” on the stock — adding upward pressure on valuation. Read More.
• Neutral Sentiment: Some brokers remain cautious: Shore Capital reaffirmed a “Hold” rating, tempering unanimity of the buy-side upgrades. Read More., Read More.
• Negative Sentiment: Intraday selling/profit‑taking: after the sharp rally on guidance and upgraded forecasts, the stock pulled back amid very heavy volume (well above average), suggesting short‑term profit taking and volatility even though the fundamental outlook was upgraded. Read More.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.